Plasma Metabolomics as Biomarkers in Depression: Betaine & Piperine Abnormalities (2024 Study)
Depression is a complex mental health disorder that affects millions worldwide, presenting a significant challenge to both diagnosis and treatment. Recent advances in metabolomics—the study of small molecules in biological systems—have opened new avenues for understanding the biochemical underpinnings of depressive disorders. By analyzing blood serum metabolites, researchers can now identify biomarkers that distinguish patients …